Looking for your next adventure?
Clip in. Help us scale new heights.
From serendipity to rational design,
taking targeted protein degradation
to new heights
OUR APPROACH
From Serendipity
The discovery of the first molecular glue degrader (MGD) was serendipitous. Fast forward to today, Monte Rosa’s team of world-leading scientists are taking a new and smarter approach. We engage the body’s natural mechanisms to selectively degrade therapeutically relevant proteins.
To
Rational Design
Architecture matters. Monte Rosa’s MGDs are rationally designed drug-like small molecules that create complementary surfaces between two proteins. We use this novel approach to degrade therapeutically relevant protein targets, including those previously considered undruggable. Learn how we are integrating artificial intelligence, chemistry, and biology to design and develop novel MGDs to precisely edit the human proteome with the potential to treat human diseases.
Our Accomplished Team
LEADERSHIP
Boston
°
Bassel
°
CAREERS